|
591 |
The European Medicines Agency Discovers the Geriatric Patient Enthalten in Drugs & aging Bd. 28, 31.8.2012, Nr. 11, date:11.2011: 849-851
|
|
|
592 |
The Evolution of Antiplatelet Therapy in the Treatment of Acute Coronary Syndromes Enthalten in Drugs Bd. 72, 25.12.2012, Nr. 16, date:12.2012: 2087-2116
|
|
|
593 |
The Evolution of Population Pharmacokinetic Models to Describe the Enterohepatic Recycling of Mycophenolic Acid in Solid Organ Transplantation and Autoimmune Disease Enthalten in Clinical pharmacokinetics Bd. 50, 30.9.2012, Nr. 1, date:1.2011: 1-24
|
|
|
594 |
The impact of CT colonography for colorectal cancer screening on the UK NHS Enthalten in Applied health economics and health policy Bd. 9, 6.8.2012, Nr. 1, date:1.2011: 51-64
|
|
|
595 |
The Impact of Training Modalities on the Clinical Benefits of Exercise Intervention in Patients with Cardiovascular Disease Risk or Type 2 Diabetes Mellitus Enthalten in Sports medicine Bd. 40, 23.9.2012, Nr. 11, date:11.2010: 921-940
|
|
|
596 |
The Impact of Upper Gastrointestinal Symptoms on Nonadherence to, and Discontinuation of, Low-Dose Acetylsalicylic Acid in Patients with Cardiovascular Risk Enthalten in American journal of cardiovascular drugs Bd. 10, 20.8.2012, Nr. 5, date:10.2010: 281-288
|
|
|
597 |
The Importance of Clinical Variables in Comparative Analyses Using Propensity-Score Matching Enthalten in PharmacoEconomics Bd. 27, 11.12.2012, Nr. 9, date:9.2009: 755-765
|
|
|
598 |
The Lack of Impact of Quality-of-Life Measures in Schizophrenia: A Shared Responsibility? Enthalten in PharmacoEconomics Bd. 30, 23.12.2012, Nr. 6, date:6.2012: 531-532
|
|
|
599 |
The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis Enthalten in American journal of clinical dermatology Bd. 12, 21.8.2012, Nr. 5, date:10.2011: 321-337
|
|
|
600 |
The New EU Legislation on Pharmacovigilance and Changing Models for Drug Development Enthalten in Drug safety Bd. 34, 20.11.2012, Nr. 6, date:6.2011: 529-530
|
|